


Efficacy of Tocilizumab Monotherapy After Ultra-Short Glucocorticoid Administration in GCA

Research Outlines Benefits of bDMARDs to Treat Early RA

RA Patients Taking Either 15 mg or 30 mg Dose of Upadacitinib Experience Improvement

RA Patients May Safely Stop Methotrexate in Tofacitinib Combination Therapy

Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector
